Bladder Cancer News

Gemzar® and Taxol® Effective First-line Therapy for Previously Untreated Bladder Cancer (May 27, 2009)

The combination of Gemzar® (gemcitabine) and Taxol® (paclitaxel) is an effective first-line treatment for bladder cancer, according to an early online publication of Cancer.[1] The bladder is a hollow organ located in the pelvis. Its primary function... Continue Reading

Delaying Surgery Shortens Survival in Stage II Bladder Cancer (March 31, 2009)

Among patients with Stage II bladder cancer, those who undergo surgery more than 12 weeks after diagnosis have a higher risk of death. These results were published in the journal Cancer. The bladder is a hollow organ in the lower abdomen. Its primary... Continue Reading

For Optimum Care of Gynecologic Cancers, Consult Your Gynecologic Oncologist About Medication Concerns (February 8, 2009)

As a patient or caregiver affected by a gynecologic cancer diagnosis, you can help your gynecologic oncologist ensure that you or your loved one receive the best possible care. Learn all about each prescribed medicine—both new drugs and routine drugs... Continue Reading

Understanding Bladder Cancer: Bladder Basics (February 4, 2009)

Learning about this often-overlooked cancer may save your life. Although it’s true that bladder cancer is most common in older men, the disease can occur in men of all ages and also affects women. In fact, more than 17,000 women in the United States... Continue Reading

Update on the Management of Genitourinary Malignancies (October 12, 2007)

Update on the Management of Genitourinary Malignancies: A Report from the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO) Kidney cancer, the orphan disease that had only one approved therapy for 15 years, once again this year stole... Continue Reading

Update on the Management of Genitourinary Malignancies (October 12, 2007)

Improved Outcomes with Higher Volumes for Radical Cystectomy (August 3, 2007)

Improved Outcomes with Higher Volumes for Radical Cystectomy According to an early online publication in the Journal of Urology, patients with bladder cancer who undergo surgery to remove their bladder have improved outcomes if they receive treatment... Continue Reading

Herceptin® Evaluated in Advanced Bladder Cancer (July 16, 2007)

Herceptin® Evaluated in Advanced Bladder Cancer According to the results of a Phase II clinical trial, Herceptin® (trastuzumab)-a targeted therapy used in the treatment of HER2-positive breast cancer-may have a role in the treatment of HER2-positive... Continue Reading

Markers Associated with Risk for Recurrence in Bladder Cancer (February 5, 2007)

Markers Associated with Risk for Recurrence in Bladder Cancer According to an article recently published in the Lancet Oncology, “markers” may help to predict the risk of cancer recurrences among patients with bladder cancer who are treated... Continue Reading

Home Screening May Reduce Death from Bladder Cancer (November 6, 2006)

Home Screening May Reduce Death from Bladder Cancer According to results recently published in the journal Cancer, at-home screening for bladder cancer may reduce deaths from the disease among men who are 50 years or older. The bladder is a hollow organ... Continue Reading